Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Presta

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|March 7, 2001
Pramipexole augmentation in panic with agoraphobiaD Marazziti, S Presta, C Pfanner, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1996
Platelet abnormalities in aggressive subjects with mental deficiencyD Marazziti, L Palego, S Silvestri, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depressionA Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology|September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label studyC Pfanner, D Marazziti, L Dell'Osso, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1995
Platelet markers in suicide attemptersD Marazziti, S Presta, S Silvestri, et al.
Neuropsychobiology|April 5, 2001
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patientsD Marazziti, L Conti, C Pfanner, et al.
International Clinical Psychopharmacology|July 19, 2001
Citalopram in refractory obsessive-compulsive disorder: an open studyD Marazziti, L Dell'Osso, A Gemignani, et al.
Neuropsychobiology|January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patientsD Marazziti, A Rossi, A Gemignani, et al.
Pharmacopsychiatry|January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramineD Marazziti, C Pfanner, L Palego, et al.
Biological Psychiatry|September 24, 1999
Immunological alterations in adult obsessive-compulsive disorderD Marazziti, S Presta, C Pfanner, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|March 7, 2001
Pramipexole augmentation in panic with agoraphobiaD Marazziti, S Presta, C Pfanner, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1996
Platelet abnormalities in aggressive subjects with mental deficiencyD Marazziti, L Palego, S Silvestri, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depressionA Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology|September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label studyC Pfanner, D Marazziti, L Dell'Osso, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1995
Platelet markers in suicide attemptersD Marazziti, S Presta, S Silvestri, et al.
Neuropsychobiology|April 5, 2001
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patientsD Marazziti, L Conti, C Pfanner, et al.
International Clinical Psychopharmacology|July 19, 2001
Citalopram in refractory obsessive-compulsive disorder: an open studyD Marazziti, L Dell'Osso, A Gemignani, et al.
Neuropsychobiology|January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patientsD Marazziti, A Rossi, A Gemignani, et al.
Pharmacopsychiatry|January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramineD Marazziti, C Pfanner, L Palego, et al.
Biological Psychiatry|September 24, 1999
Immunological alterations in adult obsessive-compulsive disorderD Marazziti, S Presta, C Pfanner, et al.
Pageof 2